264 related articles for article (PubMed ID: 15750170)
1. In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.
Kersemans V; Cornelissen B; Kersemans K; Bauwens M; Achten E; Dierckx RA; Mertens J; Slegers G
J Nucl Med; 2005 Mar; 46(3):532-9. PubMed ID: 15750170
[TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
Kersemans V; Cornelissen B; Bacher K; Kersemans K; Thierens H; Dierckx RA; De Spiegeleer B; Slegers G; Mertens J
J Nucl Med; 2005 Dec; 46(12):2104-11. PubMed ID: 16330577
[TBL] [Abstract][Full Text] [Related]
3. Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.
Kersemans V; Cornelissen B; Kersemans K; Dierckx RA; De Spiegeleer B; Mertens J; Slegers G
Nucl Med Biol; 2006 Jan; 33(1):111-7. PubMed ID: 16459266
[TBL] [Abstract][Full Text] [Related]
4. Influence of sedation and data acquisition method on tracer uptake in animal models: [123I]-2-iodo-L-phenylalanine in pentobarbital-sedated tumor-bearing athymic mice.
Kersemans V; De Spiegeleer B; Mertens J; Slegers G
Nucl Med Biol; 2006 Jan; 33(1):119-23. PubMed ID: 16459267
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, radiosynthesis, and in vitro characterization of [125I]-2- iodo-L-phenylalanine in a R1M rhabdomyosarcoma cell model as a new potential tumor tracer for SPECT.
Mertens J; Kersemans V; Bauwens M; Joos C; Lahoutte T; Bossuyt A; Slegers G
Nucl Med Biol; 2004 Aug; 31(6):739-46. PubMed ID: 15246364
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the uptake of [123/125I]-2-iodo-D-tyrosine and [123/125I]-2-iodo-L-tyrosine in R1M rhabdomyosarcoma cells in vitro and in R1M tumor-bearing Wag/Rij rats in vivo.
Bauwens M; Lahoutte T; Kersemans K; Gallez C; Bossuyt A; Mertens J
Nucl Med Biol; 2006 Aug; 33(6):735-41. PubMed ID: 16934692
[TBL] [Abstract][Full Text] [Related]
7. 123/125I-labelled 2-iodo-L: -phenylalanine and 2-iodo-D: -phenylalanine: comparative uptake in various tumour types and biodistribution in mice.
Kersemans V; Cornelissen B; Kersemans K; Bauwens M; Dierckx RA; De Spiegeleer B; Mertens J; Slegers G
Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):919-27. PubMed ID: 16572305
[TBL] [Abstract][Full Text] [Related]
8. The use of [123I]-2-iodo-L-phenylalanine as an early radiotherapy evaluation tool: in vitro R1M rabdomyosarcoma cell and in vivo mouse experiments.
Kersemans V; Vergote V; de Gelder V; Madani I; Thierens H; De Neve W; Mertens J; Slegers G; Burvenich C; Peremans K; De Spiegeleer B
Cancer Biother Radiopharm; 2008 Apr; 23(2):192-201. PubMed ID: 18454688
[TBL] [Abstract][Full Text] [Related]
9. Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain.
Lahoutte T; Mertens J; Caveliers V; Franken PR; Everaert H; Bossuyt A
J Nucl Med; 2003 Sep; 44(9):1489-94. PubMed ID: 12960197
[TBL] [Abstract][Full Text] [Related]
10. D- and L-[123I]-2-I-phenylalanine show a long tumour retention compared with D- and L-[123I]-2-I-tyrosine in R1M rhabdomyosarcoma tumour-bearing Wag/Rij rats.
Bauwens M; Lahoutte T; Kersemans K; Caveliers V; Bossuyt A; Mertens J
Contrast Media Mol Imaging; 2007 Jul; 2(4):172-7. PubMed ID: 17683118
[TBL] [Abstract][Full Text] [Related]
11. Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.
Hellwig D; Menges M; Schneider G; Moellers MO; Romeike BF; Menger MD; Kirsch CM; Samnick S
Nucl Med Biol; 2005 Feb; 32(2):137-45. PubMed ID: 15721759
[TBL] [Abstract][Full Text] [Related]
12. Increased tumor uptake of 3-(123)I-Iodo-L-alpha-methyltyrosine after preloading with amino acids: an in vivo animal imaging study.
Lahoutte T; Caveliers V; Franken PR; Bossuyt A; Mertens J; Everaert H
J Nucl Med; 2002 Sep; 43(9):1201-6. PubMed ID: 12215559
[TBL] [Abstract][Full Text] [Related]
13. p-[123I]iodo-L-phenylalanine for detection of pancreatic cancer: basic investigations of the uptake characteristics in primary human pancreatic tumour cells and evaluation in in vivo models of human pancreatic adenocarcinoma.
Samnick S; Romeike BF; Kubuschok B; Hellwig D; Amon M; Feiden W; Menger MD; Kirsch CM
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):532-41. PubMed ID: 14722685
[TBL] [Abstract][Full Text] [Related]
14. Preliminary in vivo evaluation of [131I]-2-iodo-D-phenylalanine as a potential radionuclide therapeutic agent in R1M-fluc rhabdomyosarcoma tumor-bearing NuNu mice using bioluminescent imaging.
Bauwens M; Wimana L; Keyaerts M; Peleman C; Lahoutte T; Kersemans K; Snykers S; Vinken M; Mertens J; Bossuyt A
Cancer Biother Radiopharm; 2010 Apr; 25(2):225-31. PubMed ID: 20423236
[TBL] [Abstract][Full Text] [Related]
15. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
Israel I; Brandau W; Farmakis G; Samnick S
Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
[TBL] [Abstract][Full Text] [Related]
16. Intra-individual comparison of the human biodistribution and dosimetry of the D and L isomers of 2-[123I]iodo-phenylalanine.
Bauwens M; Keyaerts M; Lahoutte T; Kersemans K; Caveliers V; Bossuyt A; Mertens J
Nucl Med Commun; 2007 Oct; 28(10):823-8. PubMed ID: 17728613
[TBL] [Abstract][Full Text] [Related]
17. Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats.
Samnick S; Richter S; Romeike BF; Heimann A; Feiden W; Kempski O; Kirsch CM
Eur J Nucl Med; 2000 Oct; 27(10):1543-51. PubMed ID: 11083545
[TBL] [Abstract][Full Text] [Related]
18. Development of a Widely Usable Amino Acid Tracer: ⁷⁶Br-α-Methyl-Phenylalanine for Tumor PET Imaging.
Hanaoka H; Ohshima Y; Suzuki Y; Yamaguchi A; Watanabe S; Uehara T; Nagamori S; Kanai Y; Ishioka NS; Tsushima Y; Endo K; Arano Y
J Nucl Med; 2015 May; 56(5):791-7. PubMed ID: 25814518
[TBL] [Abstract][Full Text] [Related]
19. Expression of L amino acid transport system 1 and analysis of iodine-123-methyltyrosine tumor uptake in a pancreatic xenotransplantation model using fused high-resolution-micro-SPECT-MRI.
von Forstner C; Zuhayra M; Ammerpohl O; Zhao Y; Tiwari S; Jansen O; Kalthoff H; Henze E; Egberts JH
Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):30-7. PubMed ID: 21269932
[TBL] [Abstract][Full Text] [Related]
20. Validation of 8-[123I]iodo-L-1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid as an imaging agent for prostate cancer in experimental models of human prostate cancer.
Samnick S; Nestle U; Wagner M; Fozing T; Schaefer A; Menger MD; Kirsch CM
Nucl Med Biol; 2007 Jan; 34(1):99-107. PubMed ID: 17210466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
